{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:12Z","timestamp":1781859252541,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023331","name":"LEO Pharma A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019922","name":"Scarring Alopecia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jid.2025.09.375","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:22:25Z","timestamp":1760498545000},"page":"1265-1270.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia"],"prefix":"10.1016","volume":"146","author":[{"given":"Aubrey","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Shokrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Correa da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Del-Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-6587","authenticated-orcid":false,"given":"Robert","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-6921","authenticated-orcid":false,"given":"Ole E.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Bacher","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-324X","authenticated-orcid":false,"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-520X","authenticated-orcid":false,"given":"Maryanne Makredes","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.09.375_bib1","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/1346-8138.17151","article-title":"Lichen planus pigmentosus successfully treated with topical delgocitinib","volume":"51","author":"Asai","year":"2024","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaad.2024.01.060","article-title":"Topical tofacitinib for patients with lichen planopilaris and\/or frontal fibrosing alopecia","volume":"90","author":"Chen","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","article-title":"Hydroxychloroquine and lichen planopilaris: efficacy and introduction of lichen planopilaris Activity Index scoring system","volume":"62","author":"Chiang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2024.09.073","article-title":"A phase 2a trial of brepocitinib for cicatricial alopecia","volume":"92","author":"David","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.19040","article-title":"Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing","volume":"183","author":"Del Duca","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaad.2021.05.016","article-title":"Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement","volume":"86","author":"Dubin","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2023.07.037","article-title":"Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: a case series and review of the literature","volume":"40","author":"Dunn","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.09.375_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/bjd\/ljae342","article-title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","volume":"192","author":"Haag","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.25259\/IJDVL_1093_2022","article-title":"Janus kinase inhibitors for alopecia areata: a narrative review","volume":"89","author":"Haughton","year":"2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.09.375_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2021.03.050","article-title":"A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results","volume":"85","author":"King","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib11","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2025.09.375_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40257-024-00912-w","article-title":"Frontal fibrosing alopecia: an update","volume":"26","author":"Messenger","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00403-022-02336-0","article-title":"A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata","volume":"315","author":"Mikhaylov","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.09.375_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2022.02.027","article-title":"Treatment of lichen planopilaris with baricitinib: a retrospective study","volume":"87","author":"Moussa","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2017.09.034","article-title":"Development and validation of the Frontal fibrosing alopecia Severity Score","volume":"78","author":"Saceda-Corralo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib16","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s13555-024-01186-0","article-title":"Enhanced insights into frontal fibrosing alopecia: advancements in pathogenesis understanding and management strategies","volume":"14","author":"Starace","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.09.375_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/ced.14615","article-title":"The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?","volume":"46","author":"Steele","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.09.375_bib18","first-page":"845","article-title":"Recommendations for risk minimization when using Janus kinase inhibitors for the treatment of chronic inflammatory skin diseases","volume":"21","author":"Wohlrab","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jid.2025.09.375_bib19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.19040","article-title":"Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing","volume":"183","author":"Del Duca","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25034062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25034062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:23:01Z","timestamp":1781857381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25034062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022202X25034062"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.09.375","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.09.375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}